Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Biological Psychiatry, 2025
MAPPING THE CEREBROSPINAL FLUID PROTEOME IN BIPOLAR DISORDER

Göteson A., Holmén-Larsson J., Celik H. et al.

Olink Target 96NeurologyCross-platform ValidationCSF

Alzheimer's & Dementia, 2025
Plasma proteomic biomarkers as mediators or moderators for the association between poor cardiovascular health and white matter microstructural integrity: The UK Biobank study

Beydoun M., Beydoun H., Noren Hooten N. et al.

Olink Explore 3072/384NeurologyPathophysiologyPlasma

Epilepsia, 2025
Distinct peripheral pro‐inflammatory profile associated with tuberous sclerosis complex and epilepsy

Balthazard R., Drouin‐Engler R., Bertrand S. et al.

Olink Target 48NeurologyPathophysiologySerum

Brain Sciences, 2025
A Pilot Proteomic Analysis of Huntington’s Disease by Functional Capacity

McGarry A., Moaddel R.

Olink Explore 3072/384NeurologyPatient StratificationCSF

Microbiome, 2025
Gut microbial dysbiosis, IgA, and Enterococcus in common variable immunodeficiency with immune dysregulation

Berbers R., Paganelli F., van Montfrans J. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySerum

British Journal of Nutrition, 2025
Associations between skeletal muscle mass and elevated blood pressure are independent of body fat: a cross-sectional study in young adult women of African ancestry

Dlamini S., Norris S., Micklesfield L.

Olink Explore 3072/384CVDPathophysiologyPlasma

Mucosal Immunology, 2025
T follicular helper cell expansion and hyperimmunoglobulinemia with spontaneous IgE production to dietary antigens in IgA-deficient mice

El Ansari Y., Kanagaratham C., Furiness K. et al.

Olink Target 48 MouseImmunological & Inflammatory DiseasesPathophysiologyMouse Serum

The Lancet Oncology, 2025
Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trial

Chong W., Low J., Tay J. et al.

Olink Explore HTOncologyImmunotherapyPathophysiologyPlasma

Discover Oncology, 2025
Combination of inflammatory proteins in serum can be used to diagnose papillary thyroid carcinoma with lymph node metastasis

Pan Y., Wang G., Chen D. et al.

Olink Target 96OncologyPatient StratificationSerum

Aging Cell, 2025
Plasma Proteomic Signature as a Predictor of Age Advancement in People Living With HIV

Navas A., Matzaraki V., van Eekeren L. et al.

Olink Explore 3072/384AgingPathophysiologyPlasma

Journal of Bone and Mineral Research, 2025
Proteins and pathways involved in inflammation are longitudinally associated with total body bone mineral density among primarily hispanic overweight/obese adolescents and young adults

Beglarian E., Chen J., Li Z. et al.

Olink Explore 3072/384Other Diseases & SyndromesPathophysiologyPlasma

Scientific Reports, 2025
Proteomic, metabolomic and lipidomic profiles in community acquired pneumonia for differentiating viral and bacterial infections

Rischke S., Gurke R., Zielbauer A. et al.

Olink Target 96Infectious DiseasesPathophysiologyPatient StratificationPlasma

ESC Heart Failure, 2025
Pro‐adrenomedullin as an independent predictive biomarker for heart failure in atrial fibrillation and flutter

Hu G., Peng X., He L. et al.

Olink Explore 3072/384CVDPatient StratificationPlasma

Nature Communications, 2025
Proteomic signature of HIV-associated subclinical left atrial remodeling and incident heart failure

Peterson T., Hahn V., Moaddel R. et al.

Olink Explore 3072/384CVDInfectious DiseasesPathophysiologyPlasma

Translational Psychiatry, 2025
Associations between biomarkers of inflammation and depressive symptoms—potential differences between diabetes types and symptom clusters of depression

Herder C., Zhu A., Schmitt A. et al.

Olink Target 96Metabolic DiseasesNeurologyPathophysiologySerum

Scientific Reports, 2025
Integrative bioinformatics approach identifies novel drug targets for hyperaldosteronism, with a focus on SHMT1 as a promising therapeutic candidate

Jia M., Lin L., Yu H. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

Nature Communications, 2025
Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients

Pickering H., Schaenman J., Phan H. et al.

Olink Target 96Immunological & Inflammatory DiseasesInfectious DiseasesPathophysiologySerum

Anesthesiology, 2025
Protein alterations in patients with delirium after cardiac surgery: An exploratory case-control sub-study of the VISION Cardiac Surgery Biobank

Spence J., Devereaux P., Bashir S. et al.

Olink Explore 3072/384NeurologyPatient StratificationSerum

Journal of Hepatology, 2025
AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: two randomized phase I trials

Armisen J., Rauschecker M., Sarv J. et al.

Olink Target 96Metabolic DiseasesHepatologyPathophysiologyPlasma

Scientific Reports, 2025
The BAMBOO method for correcting batch effects in high throughput proximity extension assays for proteomic studies

Smits H., Delemarre E., Pandit A. et al.

Olink Target 96Wider Proteomics StudiesData ScienceSerum

2647 publications